Unknown

Dataset Information

0

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.

ABSTRACT:

SUBMITTER: Muir KL 

PROVIDER: S-EPMC8063883 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer.
| S-EPMC8117965 | biostudies-literature
Unknown Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.
| S-EPMC8501343 | biostudies-literature
Unknown Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy.
| S-EPMC8212098 | biostudies-literature
Unknown Bell's palsy following the Ad26.COV2.S COVID-19 vaccination.
| S-EPMC8244554 | biostudies-literature
Unknown Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination.
| S-EPMC8421108 | biostudies-literature
Unknown Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination.
| S-EPMC8635656 | biostudies-literature
Unknown Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.
| S-EPMC8314733 | biostudies-literature
Unknown Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19.
| S-EPMC8282116 | biostudies-literature
Unknown Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review.
| S-EPMC8689609 | biostudies-literature
Unknown Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV.
| S-EPMC8689810 | biostudies-literature